IM Cannabis Corp (CSE: IMCC )

2.900 UNCHANGED

Streaming Delayed Price Updated: 1:57 PM EDT, Oct 31, 2024 Add to My Watchlist

Price and Volume

Volume	1
Open	2.900
Bid (Size)	2.700 (500)
Ask (Size)	2.850 (100)
Prev. Close	2.900
Today's Range	2.900 - 2.900
52wk Range	0.2400 - 5.000
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

The Ever-Evolving Cannabis Industry: These Are Latest Leadership Changes You Should Know About

October 10, 2024

The U.S. Hemp Roundtable made headlines in early September as its board of directors welcomed two distinguished leaders from the hemp beverage sector to its officer ranks. New York's chief equity...

Via Benzinga

IM Cannabis' $1.6M Non-Brokered Private Placement Offering, Here's What Investors Need To Know

October 04, 2024

Medical cannabis company with operations in Israel and Germany, IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC), intends to undertake a non-brokered private placement offering of up to $1,613,000 through...

Via Benzinga

Performance

YTD	+574.42%	+574.42%
1 Month	-3.33%	-3.33%
3 Month	-29.27%	-29.27%
6 Month	+137.70%	+137.70%
1 Year	+375.41%	+375.41%

More News

How Cannabis Legalization In Germany Boosted This Company's Revenue, Will Spain's Medical Marijuana Framework Do The Same?

October 02, 2024

Via Benzinga

IM Cannabis Soars: German Sales Surge 200% In First 3 Months Post-Legalization, Q2 Revenue Up 12% YoY

August 14, 2024

Via Benzinga

IM Cannabis, Organigram And Other Hot Cannabis Stocks Soon To Report Earnings, What Investors Need To Know Now

August 06, 2024

Via Benzinga

IM Cannabis Announces Major Share Consolidation Plan: What Investors Need To Know

July 05, 2024

Via Benzinga

Global Weed Business: Flora Buys Australian Vaporizers As IM Cannabis Doubles Down On Germany

June 05, 2024

Via Benzinga

IM Cannabis Doubles Down On Germany Following Legalization Policy Change, Reports YoY Drop In Q1 Gross Profit And Revenue

May 08, 2024

Via Benzinga

Avant Brands Bolsters International Growth in German Cannabis Market Through Partnership with IMC

April 04, 2024

Via ACCESSWIRE

IM Cannabis' Q4 Revenue: Gross Profit Drops Due To Negative Impact Of Israel-Hamas War, Sees Germany As Growth Opportunity

March 28, 2024

Via Benzinga

IM Cannabis Stock Drops On Q2 Earnings, CEO Touts Strategic Decisions That Led To 'Sustainable Profitability'

August 14, 2023

Via Benzinga

Avant Brands and IM Cannabis Announce the Launch of BLK MKT in Israel

October 12, 2022

Via ACCESSWIRE

IM Cannabis announces Focus Medical's Import of 400 Kilograms of Premium-Indoor-Grown Dried Cannabis from Canada to Israel

January 19, 2022

From IM Cannabis Corp.

Via AccessWire

IM Cannabis Corp. Appoints Rinat Efrima as New Chief Executive Officer of IMC Holdings, the Company’s Israeli Subsidiary

January 13, 2022

From IM Cannabis Corp.

Via AccessWire

IM Cannabis to Launch WAGNERS Brand in Germany

December 07, 2021

From IM Cannabis Corp.

Via AccessWire

IM Cannabis To Buy Jerusalem-Based Medical Marijuana Pharmacy For $4.9M In Cash And Stock

December 01, 2021

Via Benzinga

IM Cannabis to Acquire Oranim, Jerusalem's Leading Medical Cannabis Pharmacy

December 01, 2021

From IM Cannabis Corp.

Via AccessWire

IM Cannabis To Debut WAGNERS Brand In Israel After Receiving Regulatory Approval

November 30, 2021

Via Benzinga

IM Cannabis Announces Focus Medical's Receipt of Israeli Ministry of Health Import Permit; Plans to Launch WAGNERS Brand in Israel

November 29, 2021

From IM Cannabis Corp.

Via AccessWire

IM Cannabis Announces Fourth Installment of Shares in Connection with the Panaxia Transaction

November 18, 2021

From IM Cannabis Corp.

Via AccessWire

IM Cannabis Announces Third Quarter 2021 Financial Results and Provides Outlook and Business Update

November 15, 2021

From IM Cannabis Corp.

Via AccessWire

IMC Announces Third Installment of Shares in Connection with the Panaxia Transaction

October 20, 2021

From IM Cannabis Corp.

Via AccessWire

IMC Provides Further Details on Panaxia Transaction

September 08, 2021

From IM Cannabis Corp.

Via AccessWire

IM Cannabis Announces Q2 2021 Financial Results and Signing of Definitive Agreement to Acquire Vironna Pharm, Accelerating its Vertical Integration Strategy in Israel

August 16, 2021

From IM Cannabis Corp.

Via AccessWire

IMC Partners with Leading US Brand to Launch cbdMD Products in Israel and Provides Further Details on Panaxia Transaction

August 09, 2021

From IM Cannabis Corp.

Via AccessWire

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.